You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Topoisomerase I Inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroblastoma Trial in Guangzhou (Naxitamab monotherapy, GM-CSF, Irinotecan)

Recruiting
  • Neuroblastoma
  • Naxitamab monotherapy
  • +6 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 31, 2023

Metastatic Colorectal Carcinoma, Metastatic Lung Carcinoma, Metastatic Lung Small Cell Carcinoma Trial in United States

Recruiting
  • Metastatic Colorectal Carcinoma
  • +29 more
  • Los Angeles, California
  • +22 more
Jun 28, 2022

Metastatic Lung Small Cell Carcinoma, Metastatic Malignant Solid Tumor, Metastatic Neuroendocrine Carcinoma Trial in United

Recruiting
  • Metastatic Lung Small Cell Carcinoma
  • +16 more
  • Phoenix, Arizona
  • +10 more
Mar 25, 2022

Metastatic Non Small Cell Lung Cancer, Recurrent Non Small Cell Lung Cancer Trial in Philadelphia (Etirinotecan pegol

Completed
Has Results
  • Metastatic Non Small Cell Lung Cancer
  • Recurrent Non Small Cell Lung Cancer
  • Etirinotecan pegol (NKTR-102)
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Apr 1, 2020

Recurrent Small Cell Lung Carcinoma Trial in Buffalo, Rochester (Laboratory Biomarker Analysis, Pegylated Irinotecan,

Completed
Has Results
  • Recurrent Small Cell Lung Carcinoma
  • Laboratory Biomarker Analysis
  • +2 more
  • Buffalo, New York
  • +2 more
Mar 3, 2020

Adenocarcinoma Esophagus, Locally Advanced Adenocarcinoma, Siewert Type I Adenocarcinoma of Esophagogastric Junction Trial

Not yet recruiting
  • Adenocarcinoma Esophagus
  • +3 more
  • (no location specified)
Sep 13, 2023

Advanced Cancer Trial in Guangzhou (TQB2102 injection)

Not yet recruiting
  • Advanced Cancer
  • TQB2102 injection
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 23, 2023

Breast Cancer Trial in Marseille (M1774, Fulvestrant injection)

Not yet recruiting
  • Breast Cancer
  • Marseille, France
    Institut Paoli Calmettes
Aug 9, 2023

Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial (PHA-022121 low dose, PHA-022121 medium

Recruiting
  • Hereditary Angioedema
  • +11 more
  • PHA-022121 low dose
  • +3 more
  • Birmingham, Alabama
  • +7 more
Dec 5, 2022

SCLC, Small Cell Cancer, Advanced Solid Tumor Trial run by the NCI (Lurbinectedin, Berzosertib)

Recruiting
  • SCLC
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +2 more
  • Questionnaire Administration
  • Tonation Breathing Technique
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

NSCLC Trial (Phase I - Mirdametinib - Level 1, Phase II - Mirdametinib, Phase I - Mirdametinib - Level 2)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Phase I - Mirdametinib - Level 1
  • +4 more
  • (no location specified)
Jul 7, 2023

NSCLC Trial in Omaha (PLB1004)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Omaha, Nebraska
    Nebraska Cancer Specialists
Sep 19, 2023

Neurofibromatosis 1 Trial run by the National Cancer Institute (NCI) (Abemaciclib)

Recruiting
  • Neurofibromatosis 1
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

PCSK9 Inhibitor in Patients With Acute Ischemic Stroke

Not yet recruiting
  • Acute Ischemic Stroke
  • (no location specified)
Nov 14, 2023

Advanced Solid Tumor, Metastatic Solid Tumor Trial (PEP07)

Not yet recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • (no location specified)
Aug 1, 2023

Nonalcoholic Steatohepatitis Trial in Rochester (OA-235i (4 mg), OA-235i (8 mg), OA-235i Dose 3)

Recruiting
  • Nonalcoholic Steatohepatitis
  • OA-235i (4 mg)
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic
Jan 30, 2023

Advanced Solid Tumours That Are MTAP Deficient Trial in Spain, United States (AZD3470)

Not yet recruiting
  • Advanced Solid Tumours That Are MTAP Deficient
  • New Haven, Connecticut
  • +3 more
Nov 8, 2023

Healthy Trial in Neu-Ulm (Tepotinib, Omeprazole)

Completed
  • Healthy
  • Neu-Ulm, Germany
    Nuvisan GmbH
Aug 22, 2022

Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +

Not yet recruiting
  • Breast Cancer
  • +3 more
  • Miami, Florida
    University of Miami
Apr 12, 2023

Heart Failure With Reduced Ejection Fraction Trial in Porto (Sacubitril-valsartan, SGLT2 inhibitor)

Recruiting
  • Heart Failure With Reduced Ejection Fraction
  • Porto, Portugal
  • +3 more
Aug 9, 2023

Severe Aplastic Anemia, Single Lineage Cytopenias, T-LGL, Hypoplastic MDS Trial run by the National Heart, Lung, and Blood

Not yet recruiting
  • Severe Aplastic Anemia
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 23, 2023

Melanoma, Skin Cancer Trial in Tampa (Panobinostat, Ipilimumab)

Completed
Has Results
  • Melanoma
  • Skin Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 18, 2023

Solid Tumor Trial in Durham (HS-196)

Suspended
  • Solid Tumor
  • Durham, North Carolina
    Duke University Medical Center
Dec 19, 2022

HER2-positive Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Chicago, Minneapolis (ALX148, Fam-Trastuzumab

Recruiting
  • HER2-positive Breast Cancer
  • +17 more
  • ALX148
  • Fam-Trastuzumab Deruxtecan-Nxki
  • Chicago, Illinois
  • +1 more
May 19, 2023